Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
25
ADAP Quote, Financials, Valuation and Earnings
Last price:
$0.28
Seasonality move
:
-12.65%
Day range:
$0.27 - $0.28
52-week range:
$0.20 - $1.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.39x
P/B ratio:
6.03x
Volume:
245.7K
Avg. volume:
602.6K
1-year change:
-78.74%
Market cap:
$71.6M
Revenue:
$178M
EPS (TTM):
-$0.31
Earnings Data
Next earnings date for ADAP
Aug 12
2025
Most recent earnings per share
-$0.18
Missed by $0.02
(May 13/2025)
Consensus Estimate
-$0.17
(May 13/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ADAP Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $14.4M | -- | -- | -$0.10 | -- |
| 08/12/2025 | Q2 | $11.1M | -- | -- | -$0.14 | -- |
| 05/13/2025 | Q1 | $6.6M | $7.3M | -$0.18 | -$0.17 | -$0.02 |
| 03/20/2025 | Q4 | $8.2M | $3.2M | -$0.31 | -$0.15 | -$0.16 |
| 11/13/2024 | Q3 | $20.5M | $40.9M | -$0.06 | -$0.18 | $0.12 |
| 08/12/2024 | Q2 | $44.8M | $128.2M | $0.24 | -$0.20 | $0.44 |
| 05/15/2024 | Q1 | $20.5M | $5.7M | -$0.18 | -$0.20 | $0.02 |
| 03/06/2024 | Q4 | $26M | $231K | -$0.18 | -$0.17 | -$0.01 |
| 11/08/2023 | Q3 | -- | -- | -$0.18 | -$0.17 | -$0.01 |
| 08/09/2023 | Q2 | -- | -- | -$0.12 | -$0.18 | $0.06 |
| 05/12/2023 | Q1 | -- | -- | $0.01 | -$0.16 | $0.16 |
| 03/06/2023 | Q4 | -- | -- | -$0.18 | -$0.25 | $0.07 |
| 11/08/2022 | Q3 | -- | -- | -$0.24 | -$0.27 | $0.03 |
| 08/04/2022 | Q2 | -- | -- | -$0.30 | -$0.27 | -$0.03 |
| 05/09/2022 | Q1 | -- | -- | -$0.30 | -$0.26 | -$0.04 |
| 03/14/2022 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$0.30 | -$0.27 | -$0.04 |
| 08/09/2021 | Q2 | -- | -- | -$0.24 | -$0.24 | $0.00 |
| 05/06/2021 | Q1 | -- | -- | -$0.24 | -$0.25 | $0.01 |
| 02/25/2021 | Q4 | -- | -- | -$0.24 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$0.24 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$0.24 | -- | -- |
| 05/14/2020 | Q1 | -- | -- | -$0.24 | -- | -- |
| 02/27/2020 | Q4 | -- | -- | -$0.30 | -- | -- |
| 11/06/2019 | Q3 | -- | -- | -$0.36 | -- | -- |
| 08/01/2019 | Q2 | -- | -- | -$0.42 | -- | -- |
| 05/06/2019 | Q1 | -- | -- | -$0.24 | -- | -- |
| 02/27/2019 | Q4 | -- | -- | -$0.36 | -- | -- |
| 11/06/2018 | Q3 | -- | -- | $0.06 | -- | -- |
| 08/02/2018 | Q2 | -- | -- | -$0.48 | -- | -- |
| 05/09/2018 | Q1 | -- | -- | -$0.24 | -- | -- |
| 03/15/2018 | Q4 | -- | -- | -$0.30 | -- | -- |
| 11/02/2017 | Q3 | -- | -- | -$0.01 | -- | -- |
| 08/03/2017 | Q2 | -- | -- | -$0.24 | -- | -- |
| 03/31/2017 | Q1 | -- | -- | -$0.30 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | -$0.24 | -- | -- |
| 09/30/2016 | Q3 | -- | -- | -$0.24 | -- | -- |
| 06/30/2016 | Q2 | -- | -- | -$0.30 | -- | -- |
| 03/31/2016 | Q1 | -- | -- | -$0.24 | -- | -- |
| 09/30/2015 | Q3 | -- | -- | -$0.02 | -- | -- |
Adaptimmune Therapeutics PLC Earnings Questions
-
How Much did Adaptimmune Therapeutics PLC Generate in Revenue Last Quarter?
Adaptimmune Therapeutics PLC reported $7.3M worth of top line sales in its most recent quarter.
-
Did Adaptimmune Therapeutics PLC Beat Earnings Last Quarter?
Adaptimmune Therapeutics PLC announced earnings per share of -$0.18 which represents a miss of analyst forecast a -$0.17 per share.
-
Is Adaptimmune Therapeutics PLC Profitable?
Adaptimmune Therapeutics PLC reported $6.4M that represents $0.02 per share over the last quarter.
-
What is the Analyst Consensus for Adaptimmune Therapeutics PLC EPS Next Year?
Adaptimmune Therapeutics PLC's earnings are forecast to decrease from -$0.30 per share to -$0.14 per share next year representing a decrease of -66.33%.
-
When is Adaptimmune Therapeutics PLC's Earnings Date?
Adaptimmune Therapeutics PLC's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
